Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, American Bio Medica's Enterprise Value is $0.11 Mil.
American Bio Medica's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was $1.02 Mil. Therefore, American Bio Medica's EV-to-EBIT ratio for today is 0.11.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, American Bio Medica's Enterprise Value is $0.11 Mil.
American Bio Medica's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was $1.07 Mil. Therefore, American Bio Medica's EV-to-EBITDA ratio for today is 0.11.
American Bio Medica Enterprise Value Historical Data
The historical data trend for American Bio Medica's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of American Bio Medica's Enterprise Value
For the Diagnostics & Research subindustry, American Bio Medica's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Bio Medica's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, American Bio Medica's Enterprise Value distribution charts can be found below:
* The bar in red indicates where American Bio Medica's Enterprise Value falls into.
American Bio Medica Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
American Bio Medica's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Bio Medica (OTCPK:ABMC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
American Bio Medica's current Enterprise Value is $0.11 Mil.
American Bio Medica's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.02 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
American Bio Medica's current Enterprise Value is $0.11 Mil.
American Bio Medica's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.07 Mil.
American Bio Medica's current Enterprise Value is $0.11 Mil.
American Bio Medica's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.73 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Bio Medica Enterprise Value Related Terms
Thank you for viewing the detailed overview of American Bio Medica's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
American Bio Medica (American Bio Medica) Business Description
American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABMC has been successfully added to your 